Advanced HIV Disease Burden in Selected Health Facilities in Mozambique, October–December 2023
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Introduction
Advanced HIV Disease (AHD) is a remaining hurdle in the care and treatment cascade in Mozambique and has the potential to delay Mozambique’s progress towards the UNAIDS 95-95-95 goals for 2025. An improved understanding of the prevalence and demographics of AHD is critical to understanding this important condition.
Methods
Data from October to December 2023 were reviewed from the 79 health facilities implementing the AHD diagnosis and treatment package at the national level.
Results
Overall, 36% (7.811/21.452) of people living with HIV (PLHIV) newly initiated or reinitiated on treatment had a CD4 test, of which 1.986 were diagnosed with AHD. Most diagnosed cases were in the newly initiated PLHIV (1.814) versus reinitiated (179).
Conclusion
Low CD4 testing uptake means that AHD remains a serious challenge in Mozambique’s path towards the elimination of HIV as a public health threat.
